Psychiatric Morbidity in Psoriasis and Vitiligo: A Comparative Study
- 1 August 2001
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 28 (8) , 419-423
- https://doi.org/10.1111/j.1346-8138.2001.tb00003.x
Abstract
The psychiatric morbidity in psoriasis patients was compared with that in vitiligo patients using the standardised Hindi (vernacular language) version of the General Health Questionnaire (GHQ‐H). Thirty new and untreated patients each with psoriasis or vitiligo and between the ages of 18–60 yrs, constituted the study group. The prevalences of psychiatric morbidity as assessed by the GHQ‐H were found to be 53.3% and 16.22% in the psoriasis and vitiligo patients respectively; the difference was statistically significant (p=0.0028). The prevalences of depression were 23.3% and 10% in psoriasis and vitiligo respectively and anxiety was observed in 3.3% of each group. Sleep disturbance was the most common complaint and was present in 56.6% of psoriasis patients and 20% of the vitiligo patients. However, the parameter of sleep disturbance showed a statistically significant difference between the two dermatoses (p=0.0034).Keywords
This publication has 4 references indexed in Scilit:
- SUICIDAL IDEATION IN PSORIASISInternational Journal of Dermatology, 1993
- The Classification of Psychiatric Morbidity in Attenders at a Dermatology ClinicThe British Journal of Psychiatry, 1989
- Skin disease and handicap: An analysis of the impact of skin conditionsSocial Science & Medicine, 1985
- The Natural History of Psoriasis in 5,600 PatientsDermatology, 1974